Skip to content
value.today

ProPhase Labs, Inc.: timeline

Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.

83 events

On the market-cap history; source: Market-cap history on value.today.

$22 M$89 M$156 M202120222023202420252026Jun 1, 2026: Annual report filed (Form 10-K)Dec 29, 2025: Delisting noticeDec 20, 2025: Trading halted on its exchange (T3)Dec 19, 2025: Trading halted on its exchange (T3)Dec 2, 2025: 1-for-10 reverse stock splitNov 19, 2025: Results releasedAug 13, 2025: Results releasedMay 20, 2025: Results releasedMar 31, 2025: Results releasedNov 13, 2024: Results releasedSep 24, 2024: DNA Complete became a subsidiaryAug 14, 2024: Results releasedMay 9, 2024: Results releasedMar 15, 2024: Results releasedNov 9, 2023: Results releasedAug 10, 2023: Results releasedMay 11, 2023: Results releasedMar 28, 2023: Results releasedNov 10, 2022: Results releasedAug 11, 2022: Results releasedMay 13, 2022: Results releasedMar 30, 2022: Results releasedMar 10, 2022: 1 insider bought $9,532 of shares on the market2022: Record revenue of $123 millionNov 12, 2021: Results releasedAug 13, 2021: Results releasedAug 2021: Nebula Genomics became a subsidiaryJun 3, 2021: 1 insider bought $172,091 of shares on the marketMay 13, 2021: Results releasedMar 30, 2021: Results releasedNov 16, 2020: Results releasedAug 13, 2020: 1 insider bought $137,500 of shares on the marketAug 11, 2020: Results releasedMar 26, 2020: 1 insider bought $175,000 of shares on the marketMar 25, 2020: Results releasedMar 12, 2020: Results released

Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.

  1. 2026

    1. Jun 1, 2026
      Annual report filed (Form 10-K)

      For the year to 31 Dec 2025

      Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)

  2. 2025

    1. Dec 29, 2025
      Delisting notice

      The exchange told the company it no longer meets a listing rule, or the company is moving or leaving its listing (takeovers are counted separately).

      Notable 8-K events · source: SEC EDGAR (Form 8-K)

    2. Dec 20, 2025
      Trading halted on its exchange (T3)

      Resumed 22 Dec 2025 14:00 UTC

      Trading halts · source: Nasdaq Trader halt list

    3. Dec 19, 2025
      Trading halted on its exchange (T3)

      Resumed 19 Dec 2025 12:30 UTC

      Trading halts · source: Nasdaq Trader halt list

    4. Dec 2, 2025
      1-for-10 reverse stock split

      Stock splits · source: SEC filings

    5. Nov 19, 2025
      Results released

      Form 8-K filed 19 Nov 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    6. Aug 13, 2025
      Results released

      Form 8-K filed 13 Aug 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    7. May 20, 2025
      Results released

      Form 8-K filed 20 May 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    8. Mar 31, 2025
      Results released

      Form 8-K filed 31 Mar 2025

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  3. 2024

    1. Nov 13, 2024
      Results released

      Form 8-K filed 13 Nov 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Sep 24, 2024
      DNA Complete became a subsidiary

      Company history · source: Wikidata

    3. Aug 14, 2024
      Results released

      Form 8-K filed 14 Aug 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. May 9, 2024
      Results released

      Form 8-K/A filed 09 May 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Mar 15, 2024
      Results released

      Form 8-K filed 15 Mar 2024

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  4. 2023

    1. Nov 9, 2023
      Results released

      Form 8-K filed 09 Nov 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Aug 10, 2023
      Results released

      Form 8-K filed 10 Aug 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    3. May 11, 2023
      Results released

      Form 8-K filed 11 May 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Mar 28, 2023
      Results released

      Form 8-K filed 28 Mar 2023

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

  5. 2022

    1. Nov 10, 2022
      Results released

      Form 8-K filed 10 Nov 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    2. Aug 11, 2022
      Results released

      Form 8-K filed 11 Aug 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    3. May 13, 2022
      Results released

      Form 8-K filed 13 May 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    4. Mar 30, 2022
      Results released

      Form 8-K filed 30 Mar 2022

      Results releases · source: SEC EDGAR (Form 8-K, item 2.02)

    5. Mar 10, 2022
      1 insider bought $9,532 of shares on the market

      Open-market purchases between 10 Mar and 10 Mar 2022

      Insider buying and large selling · source: SEC Forms 4 and 5

    6. 2022
      Record revenue of $123 million

      FY2022, the highest of the 8 years on record.

      Company history · source: Financial years

Share price moves are worked out where the site has the listing's daily prices from the exchange itself: India (NSE), Taiwan (TWSE, TPEx), Brazil (B3), Poland (GPW), Russia (MOEX), Hong Kong (HKEX) and Sri Lanka (CSE). US listings have no daily price source on the site yet.